Is Xylem (XYL) Undervalued As Its Simplification Drive Points To Higher Margins?
Xylem (XYL) is back on investors’ radars after fresh performance data highlighted mixed recent returns, with the stock edging up over the past month but declining over the past 3 months and year to date.
See our latest analysis for Xylem.
The latest 2.5% 1 day share price gain to around $119.75 comes after a period where momentum has generally faded, with the 90 day share price return down 3% and the 1 year total shareholder return down 8.5%, even though the 3 year total shareholder return is positive at 10.3%.
If Xylem has you rethinking where growth might come from next, it could be worth scanning for companies positioned in power grid technology and infrastructure via the 35 power grid technology and infrastructure stocks
After Xylem’s latest bounce to around $119.75, the real tension is between locking in exposure now or waiting for a clearer pullback. How does the current valuation stack up against its recent performance and fundamentals?
Most Popular Narrative: 20.5% Undervalued
Based on the most followed valuation narrative, Xylem’s fair value of $150.65 sits well above the last close at $119.75, putting the focus on the assumptions behind that gap.
The company's operational simplification and implementation of the 80/20 model is already delivering record on-time performance, increased productivity, and measurable margin improvements. This is interpreted as signaling sustainable cost efficiencies and enhanced net margins moving forward.
Want to see what underpins that fair value jump for Xylem? The narrative leans on steadier growth, higher margins and a richer earnings multiple than today.
Result: Fair Value of $150.65 (UNDERVALUED)
Have a read of the narrative in full and understand what's behind the forecasts.
However, Xylem’s story could shift if government infrastructure funding is delayed, or if execution issues around acquisitions and simplification efforts weigh on margins and earnings visibility.
Find out about the key risks to this Xylem narrative.
Next Steps
If the mixed tone on Xylem has you weighing both upside and risk, consider acting promptly and stress test the numbers yourself using the 5 key rewards
Looking for more investment ideas beyond Xylem?
If Xylem has sharpened your focus on quality, do not stop here. Broaden your watchlist using focused stock ideas built from data driven screeners.
- Target potential bargains by checking companies that currently look mispriced with the 49 high quality undervalued stocks.
- Strengthen your core holdings by reviewing companies flagged in the solid balance sheet and fundamentals stocks screener (49 results).
- Get ahead of the crowd by scanning potential underfollowed opportunities through the screener containing 19 high quality undiscovered gems.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com